Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04473729Not ApplicableCompleted

Improving Perception of Speech in Noise in Children With Communication Disorders

Role: collaborator

NCT02191033Not ApplicableCompleted

Text Messaging for Smoking Cessation in College Health Clinics

Role: collaborator

NCT03717233Not ApplicableCompleted

Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics

Role: collaborator

All 3 trials loaded